Angiotensin II stimulates apoptosis via TGF-β1 signaling in ventricular cardiomyocytes of rat

Journal of Molecular Medicine

Volumn 84, Issue 11, 2006, Pages 975-983

  Schroder D ^a   Heger, J ^a   Piper, H M ^a   Euler, G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Angiotensin II; Apoptosis; Cardiomyocytes; TGF 1; Transcription factors

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN II; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGONUCLEOTIDE; SNARE PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DRUG INHIBITION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CARDIOMYOPATHIES; CELLS, CULTURED; GATA TRANSCRIPTION FACTORS; HEART VENTRICLES; MALE; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD PROTEINS; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 33750490112     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0090-0     Document Type: Article

References (42)

1. Peffer JM, Pfeffer MA (1988) Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure. Am J Med 84:37-44
2. Pinto YM, Pinto-Sietsma S-J, Philipp T, Engler S, Koßmehl P, Hocher B, Marquardt H, Sethmann S, Lauster R, Merker H-J, Paul M (2000) Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat. Hypertension 36:747-754
3. Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, Iwao H (2001) Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103:148-154
4. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293-302
5. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669-677
6. Pitt B, Poole-Wilson P, Segal R, Martinez F, Dickstein K, Camm A, Konstam M, Riegger G, Klinger G, Neaton J (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 355:1582-1587
7. Villarreal FJ, MacKenna DA, Omens JH, Dillmann WH (1995) Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension 25:98-104
8. 1 receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 282:1635-1641
9. Ravassa S, Fortuño MA, González A, López B, Zalba G, Fortuño A, Díez J (2000) Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats. Hypertension 36:1065-1071
10. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM (1993) Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72:1245-1254
11. Bouzegrhane F, Thibault G (2002) Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 53:304-312
12. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P (1997) Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 29:859-870
13. Cigola E, Kajstura J, Li B, Meggs LG, Anversa P (1997) Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 231:363-371
14. Ruf S, Piper HM, Schluter KD (2002) Specific role for the extracellular signal-regulated kinase pathway in angiotensin II-but not phenylephrine-induced cardiac hypertrophy in vitro. Pflugers Arch 443:483-490
15. Schluter KD, Zhou XJ, Piper HM (1995) Induction of hypertrophic responsiveness to isoproterenol by TGF-beta in adult rat cardiomyocytes. Am J Physiol 269:C1311-C1316
16. Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schlüter KD, Böhm M (2002) Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 283:H1253-H1262
17. Wenzel S, Taimor G, Piper HM, Sschlüter KD (2001) Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. FASEB J 15:2291-2293
18. Taimor G, Schlüter K-D, Best P, Helmig S, Piper HM (2004) Transcription activator protein 1 mediates alpha- but not beta-adrenergic hypertrophic growth responses in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 286:H2369-H2375
19. Schneiders D, Heger J, Best P, Piper HM, Taimor G (2005) SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. Cardiovasc Res 67:87-96
20. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228
21. Pikkarainen S, Tokola H, Majalahti-Palviainen T, Kerkelä R, Hautala N, Bhalla SS, Charron F, Nemer M, Vuolteenaho O, Ruskoaho H (2003) GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program. J Biol Chem 278:23807-23816
22. Molkentin JD (2000) The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275: 38949-38952
23. Moriguchi Y, Matsubara H, Mori Y, Murasawa S, Masaki H, Maruyama K, Tsutsumi Y, Shibasaki Y, Tanaka Y, Nakajima T, Oda K, Iwasaka T (1999) Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circ Res 84:1073-1084
24. Heimer R, Bashey RI, Kyle J, Jimenez SA (1995) TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J Mol Cell Cardiol 27:2191-2198
25. Dixon IM, Hao J, Reid NL, Roth JC (2000) Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. Cardiovasc Res 46:286-297
26. Hayakawa Y, Chandra M, Miao W, Shirani J, Heller Brown J, Dorn GW II, Armstrong RC, Kitsis RN (2003) Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 108:3036-3041
27. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497-1504
28. Piper HM, Probst I, Hütter JF, Spiekermann PG (1982) Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 14:397-412
29. Moniotte S, Vaerman JL, Kockx MM, Larrouy D, Langin D, Noirhomme P, Balligand JL (2001) Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J Mol Cell Cardiol 33:2121-2133
30. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
31. Taimor G, Rakow A, Piper HM (2001) Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB J 15:2518-2520
32. Taimor G, Schluter K, Piper HM (2001) Hypertrophy-associated gene induction after beta-adrenergic stimulation in adult cardiomyocytes. J Mol Cell Cardiol 33:503-511
33. Godfrey K (1985) Comparing the means of several groups. N Engl J Med 313:1450-1456
34. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
35. Omura T, Yoshiyama M, Yoshida K, Nakamura Y, Kim S, Iwao H, Takeuchi K, Yoshikawa J (2002) Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension 39:81-86
36. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A (1993) The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352-355
37. Macián F, García-Rodríguez C, Rao A (2000) Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19:4783-4795
38. Herzig TC, Jobe SM, Aoki H, Molkentin JD, Cowley AW, Izumo S, Markham BE (1997) Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci USA 94:7543-7548
39. Xia Y, McMillin JB, Lewis A, Moore M, Zhu WG, Williams RS, Kellems RE (2000) Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and upregulates the adenylosuccinate synthetase 1 gene. J Biol Chem 275:1855-1863
40. Yaar R, Cataldo LM, Tzatsos A, Francis CE, Zhao Z, Ravid K (2002) Regulation of the A3 adenosine receptor gene in vascular smooth muscle cells: role of a cAMP and GATA element. Mol Pharmacol 62:1167-1176
41. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20:2438-2452
42. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617